NT-proBNP in chronic hypercapnic respiratory failure: A marker of disease severity, treatment effect and prognosis

Respiratory Medicine

Volumn 101, Issue 9, 2007, Pages 2003-2010

  Budweiser, Stephan ^a   Luchner, Andreas ^b   Jörres, Rudolf A ^c   Heinemann, Frank ^a   Hitzl, André P ^a   Schmidbauer, Kathrin ^a,b   Riegger, Günter ^b   Pfeifer, Michael ^a,b  

^a Krankenhaus Donaustauf   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Brain natriuretic peptide; Chronic respiratory failure; Congestive heart failure; Non invasive ventilation; Right ventricular overload; Survival

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERCAPNIA; HYPOXIA; KIDNEY DYSFUNCTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; VENTILATOR;

AGED; BIOLOGICAL MARKERS; CARBON DIOXIDE; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXYGEN; PARTIAL PRESSURE; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 34547463766     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.04.001     Document Type: Article

References (35)

1. Masson S., Latini R., Anand I.S., et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52 (2006) 1528-1538
2. Morrow D.A., de Lemos J.A., Blazing M.A., et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. J Am Med Assoc 294 (2005) 2866-2871
3. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
4. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
5. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209
6. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 345-353
7. Phua J., Lim T.K., and Lee K.H. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 33 (2005) 2013-2094
8. Leuchte H.H., Baumgartner R.A., Nounou M.E., et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 173 (2006) 744-750
9. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1 (1981) 681-686
10. Ando T., Ogawa K., Yamaki K., Hara M., and Takagi K. Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases. Chest 110 (1996) 462-468
11. Schonhofer B., Barchfeld T., Wenzel M., and Kohler D. Long term effects of non-invasive mechanical ventilation on pulmonary haemodynamics in patients with chronic respiratory failure. Thorax 56 (2001) 524-528
12. Thorens J.B., Ritz M., Reynard C., et al. Haemodynamic and endocrinological effects of noninvasive mechanical ventilation in respiratory failure. Eur Respir J 10 (1997) 2553-2559
13. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation-a consensus conference report. Chest 116 (1999) 521-534
14. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 152 (1995) S77-S121
15. Luchner A., Hengstenberg C., Lowel H., Riegger G.A., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123
16. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 5-40
17. Budweiser S., Heinemann F., Fischer W., Dobroschke J., and Pfeifer M. Long-term reduction of hyperinflation in stable COPD by non-invasive nocturnal home ventilation. Respir Med 99 (2005) 976-984
18. Hosoda K., Nakao K., Mukoyama M., et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 17 (1991) 1152-1155
19. Clerico A., and Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50 (2004) 33-50
20. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
21. Berdague P., Caffin P.Y., Barazer I., et al. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J 151 (2006) 690-698
22. Goetze J.P., Videbaek R., Boesgaard S., Aldershvile J., Rehfeld J.F., and Carlsen J. Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J Heart Lung Transplant 23 (2004) 80-87
23. Bando M., Ishii Y., Sugiyama Y., and Kitamura S. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 93 (1999) 507-514
24. Souza R., Jardim C., Julio Cesar F.C., Silveira L.M., Rabelo R., and Humbert M. NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respir Med 101 (2007) 69-75
25. Toth M., Vuorinen K.H., Vuolteenaho O., et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 266 (1994) H1572-H1580
26. Clozel J.P., Saunier C., Hartemann D., Allam M., and Fischli W. Effects of hypoxia and hypercapnia on atrial natriuretic factor and plasma renin activity in conscious dogs. Clin Sci 76 (1989) 249-254
27. Wright J.L., Levy R.D., and Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax 60 (2005) 605-609
28. Abroug F., Ouanes-Besbes L., Nciri N., et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 174 (2006) 990-996
29. Leuchte H.H., Neurohr C., Baumgartner R., et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 170 (2004) 360-365
30. Mukerjee D., Yap L.B., Holmes A.M., et al. Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension. Respir Med 97 (2003) 1230-1236
31. Hesselstrand R., Ekman R., Eskilsson J., et al. Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001. Rheumatology 44 (2005) 366-371
32. Costello-Boerrigter L.C., and Burnett Jr. J.C. The prognostic value of N-terminal proB-type natriuretic peptide. Nat Clin Pract Cardiovasc Med 2 (2005) 194-201
33. Kucher N., Printzen G., and Goldhaber S.Z. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107 (2003) 2545-2547
34. Fijalkowska A., Kurzyna M., Torbicki A., et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 129 (2006) 1313-1321
35. Ishii J., Nomura M., Ito M., et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 301 (2000) 19-30